Dr Muhammed Afolabi

Muhammed Afolabi is a clinical assistant professor at the London School of Hygiene & Tropical Medicine in the UK. He obtained a medical degree from the University of Ibadan, a master’s degree in public health from Obafemi Awolowo University, both in Nigeria, and a PhD from the London School of Hygiene & Tropical Medicine in the UK. He is also a fellow of the West African College of Physicians and National Postgraduate College of Nigeria in Family Medicine, as well as the UK Higher Education Academy.

Muhammed has worked extensively on the clinical vaccine trials related to the control and prevention of Ebola, HIV, and malaria in several African countries. He led the Ebola paediatric vaccine trials in Sierra Leone, whose findings contributed to the approval of the novel two-dose Ebola vaccine regimen (ZABDENO/MVABEA) by the European Medicines Agency. Muhammed is currently working on a prestigious UKRI Future Leaders Fellowship, designed to tackle the difficult and novel challenges posed by co-endemicity of malaria and helminths in a high-risk paediatric population by investigating the feasibility and effectiveness of integrating helminth control with seasonal malaria chemoprevention (SMC). This adventurous programme will hopefully lead to the implementation of an increasingly recognised strategy of integrated, non-disease specific approach to controlling tropical anaemia.